![](/img/cover-not-exists.png)
In Vitro and In Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer
Bentzien, Frauke, Zuzow, Marcus, Heald, Nathan, Gibson, Anna, Shi, Yongchang, Goon, Leanne, Yu, Peiwen, Engst, Stefan, Zhang, Wentao, Huang, Donghui, Zhao, Lora, Vysotskaia, Valentina, Chu, Felix, BauVolume:
23
Language:
english
Journal:
Thyroid
DOI:
10.1089/thy.2013.0137
Date:
December, 2013
File:
PDF, 401 KB
english, 2013